Moreover, RNA-seq analysis revealed that the SVF-treated group exhibited significantly reduced expression levels of Fn1, Col1a2, and Acta2, suggesting that SVF may attenuate renal fibrosis progression (Figure 3F). This evidence concerns the gene COL1A2 and renal fibrosis.